Terms: = Breast cancer AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1 AND Diagnosis
47 results:
1. Three birds one stone: an enzyme-activatable theragnostic agent for fluorescence diagnosis, photodynamic and inhibitor therapies.
Yue X; Wang B; Lan M; Fan J; Song X; Foley JW
Chem Commun (Camb); 2023 Apr; 59(31):4676-4679. PubMed ID: 36995030
[TBL] [Abstract] [Full Text] [Related]
2. Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception.
Bychkovsky BL; Lo MT; Yussuf A; Horton C; Hemyari P; LaDuca H; Garber JE; Scheib R; Rana HQ
Breast Cancer Res Treat; 2023 Jul; 200(1):63-72. PubMed ID: 36856935
[TBL] [Abstract] [Full Text] [Related]
3. Interdisciplinary risk counseling for hereditary breast and ovarian cancer: real-world data from a specialized center.
Zang B; Helms M; Besch L; Kalmbach N; Stegen S; Blohmer JU; Speiser D
Arch Gynecol Obstet; 2023 May; 307(5):1585-1592. PubMed ID: 36307613
[TBL] [Abstract] [Full Text] [Related]
4. Germline Variants in 32 cancer-Related Genes among 700 Chinese breast cancer Patients by Next-Generation Sequencing: A Clinic-Based, Observational Study.
Yang L; Xie F; Liu C; Zhao J; Hu T; Wu J; Zhao X; Wang S
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232564
[TBL] [Abstract] [Full Text] [Related]
5. Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging.
Jugniot N; Massoud TF; Dahl JJ; Paulmurugan R
J Nanobiotechnology; 2022 Jun; 20(1):267. PubMed ID: 35689262
[TBL] [Abstract] [Full Text] [Related]
6. Combined legumain- and integrin-targeted nanobubbles for molecular ultrasound imaging of breast cancer.
Mi X; Guo X; Du H; Han M; Liu H; Luo Y; Wang D; Xiang R; Yue S; Zhang Y; Tan X
Nanomedicine; 2022 Jun; 42():102533. PubMed ID: 35150904
[TBL] [Abstract] [Full Text] [Related]
7. MXene-Derived Quantum Dot@Gold Nanobones Heterostructure-Based Electrochemiluminescence Sensor for Triple-Negative breast cancer diagnosis.
Nie Y; Liang Z; Wang P; Ma Q; Su X
Anal Chem; 2021 Dec; 93(51):17086-17093. PubMed ID: 34914874
[TBL] [Abstract] [Full Text] [Related]
8. Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics.
Bychkovsky BL; Lo MT; Yussuf A; Horton C; Richardson M; LaDuca H; Garber JE; Rana HQ
Cancer; 2022 Mar; 128(6):1275-1283. PubMed ID: 34875721
[TBL] [Abstract] [Full Text] [Related]
9. Nanobody-Based Theranostic Agents for HER2-Positive breast cancer: Radiolabeling Strategies.
Hrynchak I; Santos L; Falcão A; Gomes CM; Abrunhosa AJ
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639086
[TBL] [Abstract] [Full Text] [Related]
10. Therapeutic efficacy and cardioprotection of nucleolin-targeted doxorubicin-loaded ultrasound nanobubbles in treating triple-negative breast cancer.
Fang K; Wang L; Huang H; Dong S; Guo Y
Nanotechnology; 2021 Mar; 32(24):. PubMed ID: 33690196
[TBL] [Abstract] [Full Text] [Related]
11. Gene Sequencing for Pathogenic Variants Among Adults With breast and Ovarian cancer in the Caribbean.
George SHL; Donenberg T; Alexis C; DeGennaro V; Dyer H; Yin S; Ali J; Butler R; Chin SN; Curling D; Lowe D; Lunn J; Turnquest T; Wharfe G; Cerbon D; Barreto-Coelho P; Schlumbrecht MP; Akbari MR; Narod SA; Hurley JE
JAMA Netw Open; 2021 Mar; 4(3):e210307. PubMed ID: 33646313
[TBL] [Abstract] [Full Text] [Related]
12. Co-occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome.
Ferrer-Avargues R; Castillejo MI; Dámaso E; Díez-Obrero V; Garrigos N; Molina T; Codoñer-Alejos A; Segura Á; Sánchez-Heras AB; Castillejo A; Soto JL
Cancer Commun (Lond); 2021 Mar; 41(3):218-228. PubMed ID: 33630411
[TBL] [Abstract] [Full Text] [Related]
13. Genomic Sequencing for Newborn Screening: Results of the NC NEXUS Project.
Roman TS; Crowley SB; Roche MI; Foreman AKM; O'Daniel JM; Seifert BA; Lee K; Brandt A; Gustafson C; DeCristo DM; Strande NT; Ramkissoon L; Milko LV; Owen P; Roy S; Xiong M; Paquin RS; Butterfield RM; Lewis MA; Souris KJ; Bailey DB; Rini C; Booker JK; Powell BC; Weck KE; Powell CM; Berg JS
Am J Hum Genet; 2020 Oct; 107(4):596-611. PubMed ID: 32853555
[TBL] [Abstract] [Full Text] [Related]
14. Construction of Nucleolin-Targeted Lipid Nanobubbles and Contrast-Enhanced Ultrasound Molecular Imaging in Triple-Negative breast cancer.
Fang K; Wang L; Huang H; Lan M; Shen D; Dong S; Guo Y
Pharm Res; 2020 Jul; 37(7):145. PubMed ID: 32666304
[TBL] [Abstract] [Full Text] [Related]
15. Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.
da Costa E Silva Carvalho S; Cury NM; Brotto DB; de Araujo LF; Rosa RCA; Texeira LA; Plaça JR; Marques AA; Peronni KC; Ruy PC; Molfetta GA; Moriguti JC; Carraro DM; Palmero EI; Ashton-Prolla P; de Faria Ferraz VE; Silva WA
BMC Med Genomics; 2020 Feb; 13(1):21. PubMed ID: 32039725
[TBL] [Abstract] [Full Text] [Related]
16. Association of Germline Genetic Testing Results With Locoregional and Systemic Therapy in Patients With breast cancer.
Kurian AW; Ward KC; Abrahamse P; Hamilton AS; Deapen D; Morrow M; Jagsi R; Katz SJ
JAMA Oncol; 2020 Apr; 6(4):e196400. PubMed ID: 32027353
[TBL] [Abstract] [Full Text] [Related]
17. High risk of breast cancer in women with biallelic pathogenic variants in CHEK2.
Rainville I; Hatcher S; Rosenthal E; Larson K; Bernhisel R; Meek S; Gorringe H; Mundt E; Manley S
Breast Cancer Res Treat; 2020 Apr; 180(2):503-509. PubMed ID: 31993860
[TBL] [Abstract] [Full Text] [Related]
18. Radiographic Surveillance of Patients with Non-BRCA1/2 Pathogenic Variants.
Hudson L; Gower N; Lenarcic S; Trufan SJ; White RL
Ann Surg Oncol; 2020 Jul; 27(7):2248-2254. PubMed ID: 31974710
[TBL] [Abstract] [Full Text] [Related]
19. Older breast cancer survivors may harbor hereditary cancer predisposition pathogenic variants and are at risk for clonal hematopoiesis.
Slavin TP; Sun CL; Chavarri-Guerra Y; Sedrak MS; Katheria V; Castillo D; Herzog J; Dale W; Hurria A; Weitzel JN
J Geriatr Oncol; 2020 Mar; 11(2):316-319. PubMed ID: 31575519
[TBL] [Abstract] [Full Text] [Related]
20. Double heterozygous mutation in the BRCA1 and ATM genes involved in development of primary metachronous tumours: a case report.
Andrés R; Menao S; Arruebo M; Quílez E; Cardiel MJ
Breast Cancer Res Treat; 2019 Oct; 177(3):767-770. PubMed ID: 31292799
[TBL] [Abstract] [Full Text] [Related]
[Next]